# Membio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/membio

- Industry: Biotechnology
- Headquarters: Mississauga, Canada
- Website: www.membio.ca
- Latest round: Seed (Apr 9, 2020)
- Investors on record: 2

## About

Membio Inc., based in Canada, is a biotechnology company focused on developing innovative solutions within the bio sector, particularly targeting advancements in biomanufacturing and sustainable practices.Membio Inc. specializes in biotechnology solutions aimed at enhancing biomanufacturing processes. Founded in 2018 in Mississauga, Canada, the company has undergone strategic pivots to refine its operational focus. The founders, Ashley Keefner and Tracy Weir, alongside CEO Shane Kilpatrick, have led the company through three notable funding rounds, with the latest being a GRANT of CAD 0.020 mn from lead investor Velocity on April 9, 2020.Membio Inc. delivers a comprehensive suite of biotechnological solutions designed to enhance biomanufacturing processes. Their offerings include advanced bioengineering tools and sustainable production methodologies aimed at improving operational efficiencies in various industries. The products are developed to address the increasing demand for eco-friendly manufacturing alternatives, with a customer base that includes biotechnology firms and research institutions across North America, Europe, and Asia.The company generates revenue through a subscription-based model that provides clients access to their suite of biotechnological solutions. Clients typically engage in yearly contracts that offer continuous updates and support for their biomanufacturing needs. The pricing structure is designed to cater to the unique requirements of their diverse clientele, ensuring sustainable revenue streams through premium offerings and potential partnerships with other industry players.Membio Inc. plans to expand its product portfolio with the introduction of new biotechnological tools aimed at enhancing efficiency by 2023. The company is also targeting growth in the Asian market, with a focus on establishing a presence in key regions by 2024. The funding raised in April 2020 will support these initiatives, allowing the company to invest in research and development, as well as marketing efforts to solidify their market entry.

## Funding rounds

- Seed, Apr 9, 2020 — SOSV, IndieBio
- Seed, Jul 22, 2019 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed